Year |
Citation |
Score |
2013 |
McCoy A, Besch-Williford CL, Franklin CL, Weinstein EJ, Cui X. Creation and preliminary characterization of a Tp53 knockout rat. Disease Models & Mechanisms. 6: 269-78. PMID 22917926 DOI: 10.1242/Dmm.009704 |
0.365 |
|
2010 |
Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ. Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Letters. 293: 220-9. PMID 20144850 DOI: 10.1016/j.canlet.2010.01.014 |
0.403 |
|
2010 |
Yang C, Ji D, Weinstein EJ, Choy E, Hornicek FJ, Wood KB, Liu X, Mankin H, Duan Z. The kinase Mirk is a potential therapeutic target in osteosarcoma. Carcinogenesis. 31: 552-8. PMID 20042639 DOI: 10.1093/carcin/bgp330 |
0.306 |
|
2007 |
Ji D, Deeds SL, Weinstein EJ. A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity. Oncology Reports. 18: 1499-505. PMID 17982636 |
0.345 |
|
2006 |
Weinstein EJ, Head R, Griggs DW, Sun D, Evans RJ, Swearingen ML, Westlin MM, Mazzarella R. VCC-1, a novel chemokine, promotes tumor growth. Biochemical and Biophysical Research Communications. 350: 74-81. PMID 16989774 DOI: 10.1016/j.bbrc.2006.08.194 |
0.448 |
|
2005 |
Hardwick JS, Yang Y, Zhang C, Shi B, McFall R, Koury EJ, Hill SL, Dai H, Wasserman R, Phillips RL, Weinstein EJ, Kohl NE, Severino ME, Lamb JR, Sepp-Lorenzino L. Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Molecular Cancer Therapeutics. 4: 413-25. PMID 15767550 DOI: 10.1158/1535-7163.MCT-04-0209 |
0.377 |
|
2003 |
Swearingen ML, Sun D, Bourner M, Weinstein EJ. Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array. Cancer Letters. 198: 229-39. PMID 12957362 DOI: 10.1016/S0304-3835(03)00313-6 |
0.395 |
|
2000 |
Weinstein EJ, Leder P. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Cancer Research. 60: 3856-61. PMID 10919660 |
0.545 |
|
2000 |
Weinstein EJ, Kitsberg DI, Leder P. A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene. Molecular Medicine (Cambridge, Mass.). 6: 4-16. PMID 10803404 DOI: 10.1007/Bf03401930 |
0.445 |
|
1998 |
Weinstein EJ, Grimm S, Leder P. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene. 17: 2107-13. PMID 9798682 DOI: 10.1038/Sj.Onc.1202428 |
0.537 |
|
1998 |
Grimm S, Weinstein EJ, Krane IM, Leder P. Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo. The Journal of Experimental Medicine. 188: 1535-9. PMID 9782131 DOI: 10.1084/Jem.188.8.1535 |
0.513 |
|
1998 |
Tulchin N, Ornstein L, Bleiweiss IJ, Mendlowitz M, Weinstein E, Dikman SH. Nucleolar localization of BRCA1 protein in human breast cancer International Journal of Oncology. 13: 513-518. PMID 9683786 |
0.306 |
|
Low-probability matches (unlikely to be authored by this person) |
2007 |
Ji D, Deeds SL, Weinstein EJ. shRNAs targeting tumor suppressor genes Genetic Engineering and Biotechnology News. 27: 26-27. |
0.294 |
|
2003 |
Weinstein EJ, Bourner M, Head R, Zakeri H, Bauer C, Mazzarella R. URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas. Biochimica Et Biophysica Acta. 1637: 207-16. PMID 12697302 DOI: 10.1016/S0925-4439(03)00035-8 |
0.251 |
|
2008 |
Duan Z, Weinstein EJ, Ji D, Ames RY, Choy E, Mankin H, Hornicek FJ. Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer. Molecular Cancer Therapeutics. 7: 2377-85. PMID 18687998 DOI: 10.1158/1535-7163.MCT-08-0316 |
0.231 |
|
2016 |
Bishop KA, Harrington A, Kouranova E, Weinstein EJ, Rosen CJ, Cui X, Liaw L. CRISPR/Cas9 Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells. G3 (Bethesda, Md.). PMID 27175020 DOI: 10.1534/G3.116.030601 |
0.229 |
|
2010 |
Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L, Cui X. Targeted genome modification in mice using zinc-finger nucleases. Genetics. 186: 451-9. PMID 20628038 DOI: 10.1534/Genetics.110.117002 |
0.21 |
|
2011 |
Cui X, Ji D, Fisher DA, Wu Y, Briner DM, Weinstein EJ. Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nature Biotechnology. 29: 64-7. PMID 21151125 DOI: 10.1038/nbt.1731 |
0.207 |
|
2012 |
Zschemisch NH, Glage S, Wedekind D, Weinstein EJ, Cui X, Dorsch M, Hedrich HJ. Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. Bmc Immunology. 13: 60. PMID 23136839 DOI: 10.1186/1471-2172-13-60 |
0.196 |
|
2014 |
Hamilton SM, Green JR, Veeraragavan S, Yuva L, McCoy A, Wu Y, Warren J, Little L, Ji D, Cui X, Weinstein E, Paylor R. Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behavioral Neuroscience. 128: 103-9. PMID 24773431 DOI: 10.1037/a0035988 |
0.192 |
|
2012 |
Duranthon V, Beaujean N, Brunner M, Odening KE, Santos AN, Kacskovics I, Hiripi L, Weinstein EJ, Bosze Z. On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools. Transgenic Research. 21: 699-713. PMID 22382461 DOI: 10.1007/s11248-012-9599-x |
0.187 |
|
2013 |
Brown AJ, Fisher DA, Kouranova E, McCoy A, Forbes K, Wu Y, Henry R, Ji D, Chambers A, Warren J, Shu W, Weinstein EJ, Cui X. Whole-rat conditional gene knockout via genome editing. Nature Methods. 10: 638-40. PMID 23749298 DOI: 10.1038/nmeth.2516 |
0.18 |
|
2004 |
Cheng D, Yadav N, King RW, Swanson MS, Weinstein EJ, Bedford MT. Small molecule regulators of protein arginine methyltransferases. The Journal of Biological Chemistry. 279: 23892-9. PMID 15056663 DOI: 10.1074/Jbc.M401853200 |
0.157 |
|
2016 |
Sato K, Oiwa R, Kumita W, Henry R, Sakuma T, Ito R, Nozu R, Inoue T, Katano I, Sato K, Okahara N, Okahara J, Shimizu Y, Yamamoto M, Hanazawa K, ... ... Weinstein EJ, et al. Generation of a Nonhuman Primate Model of Severe Combined Immunodeficiency Using Highly Efficient Genome Editing. Cell Stem Cell. PMID 27374787 DOI: 10.1016/J.Stem.2016.06.003 |
0.141 |
|
2015 |
Ji D, Zhao G, Songstad A, Cui X, Weinstein EJ. Efficient creation of an APOE knockout rabbit. Transgenic Research. 24: 227-35. PMID 25216764 DOI: 10.1007/s11248-014-9834-8 |
0.139 |
|
2011 |
Jay GW, Demattos RB, Weinstein EJ, Philbert MA, Pardo ID, Brown TP. Animal models for neural diseases. Toxicologic Pathology. 39: 167-9. PMID 21119053 DOI: 10.1177/0192623310389478 |
0.111 |
|
2006 |
Yano T, Li LS, Weinstein E, Teh JS, Rubin H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). The Journal of Biological Chemistry. 281: 11456-63. PMID 16469750 DOI: 10.1074/Jbc.M508844200 |
0.104 |
|
1957 |
WEINSTEIN EJ, LEIN A. The response of isolated rat diaphragm to thyroxine in vitro. Endocrinology. 61: 79-84. PMID 13437957 DOI: 10.1210/endo-61-1-79 |
0.098 |
|
2012 |
Vaira S, Yang C, McCoy A, Keys K, Xue S, Weinstein EJ, Novack DV, Cui X. Creation and preliminary characterization of a leptin knockout rat. Endocrinology. 153: 5622-8. PMID 22948215 DOI: 10.1210/en.2012-1462 |
0.093 |
|
1991 |
Weinstein EJ, Au PK. Use of hypnosis before and during angioplasty. The American Journal of Clinical Hypnosis. 34: 29-37. PMID 1951141 DOI: 10.1080/00029157.1991.10402957 |
0.04 |
|
2012 |
Khan BA, Zawahiri M, Campbell NL, Fox GC, Weinstein EJ, Nazir A, Farber MO, Buckley JD, Maclullich A, Boustani MA. Delirium in hospitalized patients: implications of current evidence on clinical practice and future avenues for research--a systematic evidence review. Journal of Hospital Medicine. 7: 580-9. PMID 22684893 DOI: 10.1002/jhm.1949 |
0.022 |
|
1991 |
Moore JS, Weinstein EJ, Wu Z. A convenient masking group for aryl iodides Tetrahedron Letters. 32: 2465-2466. DOI: 10.1016/S0040-4039(00)74354-1 |
0.01 |
|
Hide low-probability matches. |